CN103705722A - Formula of drug for treating psoriasis - Google Patents
Formula of drug for treating psoriasis Download PDFInfo
- Publication number
- CN103705722A CN103705722A CN201210412884.2A CN201210412884A CN103705722A CN 103705722 A CN103705722 A CN 103705722A CN 201210412884 A CN201210412884 A CN 201210412884A CN 103705722 A CN103705722 A CN 103705722A
- Authority
- CN
- China
- Prior art keywords
- radix
- drug
- grams
- rate
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A formula of a drug for treating psoriasis comprises 11-14wt% of unprepared rehmannia root, 5-7.5wt% of Radix Scrophulariae, 4-6wt% of Radix Ophiopogonis, 3-4.6wt% of Rhizoma Coptidis, 4-6wt% of Radix Scutellariae, 11-14wt% of honeysuckle flower, 11-14wt% of Folium Isatidis, 11-14wt% of Hedyotis diffusa, 3.5-5wt% of Chinese angelica, 11-14wt% of Salvia miltiorrhiza, 5-7.5wt% of ground beetle and 5-7.5wt% of jujube. The above components are decocted with water. 15 days are a treatment course. The drug has the effects of yin nourishing, blood cooling, detoxifying and blood stasis dispersing, and is a good drug mainly used for treating the psoriasis. Years of clinic application shows that 110 patients are treated by using the drug, the cure rate is 60%, the effectual rate is 19.2%, the effective rate is 14.5%, the ineffective rate is 6.3%, and the total effective rate is 93.7%. The drug has the advantages of no toxic side effects, no drug dependency, simple formula, taking convenience, low cost, good curative effect and high cure rate.
Description
Technical field
The present invention relates to technical field of Chinese medicines, is a kind of psoriatic prescription for the treatment of specifically.
Background technology
Psoriasis claims again psoriasis, is a kind of chronic dermatosis of agnogenio and easy recurrence.Men and women, old and young all can fall ill, in the majority with person between twenty and fifty.Primary disease can involve any position of health, but is apt to occur in scalp, and trunk and extremity are stretched side.Often accompany that scabies is overworked in various degree.Be divided into clinically homeliness type, pustule type, arthritis type, erythrodermic.
Psoriasis etiology unknown, modern medicine is thought may be relevant with heredity, infection, dysbolismus, endocrine impact, neural Nervous and Mental Factors or dysimmunity.
Modern medicine mainly adopts immunosuppressive drug to the treatment of primary disease, corticosteroid hormone, vitamins and vein sealing etc.But mostly can only reach short-term effect, and have certain side effect.
Motherland's medical science thinks that psoriasis is how damp and hot by spleen lung, feels again rheumatism pathogenic heat, accumulates in skin, cause local QI-blood circulation lose smooth, gas Yu Ze heat-dissipating of a specified duration, or because of affection by exopathogenic cold-wind, battalion defends imbalance, strongly fragrant dryness-transformation of a specified duration make skin lose support and form.Or because of internal injury caused by excess of seven emotions obstruction of QI, the strongly fragrant or stasis of blood of a specified duration, thus face disease dividing " heat in blood ", " blood is dry ", types such as " blood stasis " treats.
Summary of the invention
Content of the present invention is invented a kind of psoriatic prescription for the treatment of that is used for the treatment of exactly.The technical solution used in the present invention is, a kind ofly treats psoriatic prescription, comprising:
Constituent is: the Radix Rehmanniae, Radix Scrophulariae, Radix Ophiopogonis, Rhizoma Coptidis, Radix Scutellariae, Flos Lonicerae, Folium Isatidis, Hedyotidis Diffusae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, eupolyphaga, Fructus Jujubae;
Constituent weight percent is: Radix Rehmanniae 11-14%, Radix Scrophulariae 5-7.5%, Radix Ophiopogonis 4-6%, Rhizoma Coptidis 3-4.6%, Radix Scutellariae 4-6%, Flos Lonicerae 11-14%, Folium Isatidis 11-14%, Hedyotidis Diffusae 11-14%, Radix Angelicae Sinensis 3.5-5%, Radix Salviae Miltiorrhizae 11-14%, eupolyphaga 5-7.5%, Fructus Jujubae 5-7.5%;
Manufacture method and usage: be decocted in water for oral dose.Every day, potion, decocted three times, and after mixing, a minute secondary is taken, sooner or later respectively take once half an hour ante cibum, and within 15 days, be a course for the treatment of.
In prescription of the present invention, the Radix Rehmanniae, Radix Scrophulariae, can play a role Radix Ophiopogonis to the two-ways regulation of cyclic nucleotide in human body, the Radix Rehmanniae has the effect of adrenocortical hormone sample, make the synthetic ratio of DNA in epidermis cell have the hyperfunction attenuating that is converted into, Rhizoma Coptidis, the Radix Astragali, Folium Isatidis, Hedyotidis Diffusae has immunoregulation effect, the Radix Astragali wherein, Rhizoma Coptidis has antiallergic action and reduces the effect of vascular permeability, in Folium Isatidis, effective ingredient indirubin has the metabolism of intervening intracellular nucleic acid and protein, suppress the synthetic effect of DNA, Flos Lonicerae suppresses inflammatory exudation and hypertrophy, Hedyotidis Diffusae is dual regulation to immunological enhancement and inhibition, Radix Angelicae Sinensis, Radix Scrophulariae, eupolyphaga may generate by the activity of activated adenyl cyclase more CAMP, play and suppress epidermis cell hyperplasia and splitting action, Fructus Jujubae includes a large amount of CAMP sample materials, likely the hypertrophy division of the immune system of body and cell is played to favourable regulating action.
Technique effect
Technique effect of the present invention is, adopts above-mentioned technical scheme, can realize a kind of psoriatic prescription for the treatment of, and it has phencyclidine, the effect of eliminating toxic substances to remove stasis.The good medicine for the treatment of psoriasis.
Through clinical practice for many years, treatment 110 examples, recovery from illness 60%, effective 19.2%, effective 14.5%, invalid 6.3%, total effective rate 93.7%.This medicine is without any side effects, and without drug dependence, formula is simple, taking convenience, and cost is low, good effect, cure rate is high.
The specific embodiment
Embodiment 1
Take 30 grams, the Radix Rehmanniae, 15 grams of Radix Scrophulariaes, 12 grams of Radix Ophiopogonis, 9 grams of Rhizoma Coptidis, 12 grams of Radix Scutellariaes, 30 grams of Flos Loniceraes, 30 grams of Folium Isatidiss, 30 grams of Hedyotidis Diffusaes, 10 grams of Radix Angelicae Sinensis, 30 grams of Radix Salviae Miltiorrhizaes, 15 grams of eupolyphaga, 15 grams, Fructus Jujubae.
Be decocted in water for oral dose.Every day, potion, decocted three times, and after mixing, a minute secondary is taken, sooner or later respectively take once half an hour ante cibum, and within 15 days, be a course for the treatment of.
Embodiment 2
Take 25 grams, the Radix Rehmanniae, 20 grams of Radix Scrophulariaes, 18 grams of Radix Ophiopogonis, 12 grams of Rhizoma Coptidis, 12 grams of Radix Scutellariaes, 15 grams of Flos Loniceraes, 18 grams of Folium Isatidiss, 25 grams of Hedyotidis Diffusaes, 10 grams of Radix Angelicae Sinensis, 30 grams of Radix Salviae Miltiorrhizaes, 15 grams of eupolyphaga, 15 grams, Fructus Jujubae.
Be decocted in water for oral dose.Every day, potion, decocted three times, and after mixing, a minute secondary is taken, sooner or later respectively take once half an hour ante cibum, and within 15 days, be a course for the treatment of.
Embodiment 3
Take 30 grams, the Radix Rehmanniae, 20 grams of Radix Scrophulariaes, 20 grams of Radix Ophiopogonis, 12 grams of Rhizoma Coptidis, 15 grams of Radix Scutellariaes, 20 grams of Flos Loniceraes, 25 grams of Folium Isatidiss, 30 grams of Hedyotidis Diffusaes, 15 grams of Radix Angelicae Sinensis, 30 grams of Radix Salviae Miltiorrhizaes, 15 grams of eupolyphaga, 15 grams, Fructus Jujubae.
Be decocted in water for oral dose.Every day, potion, decocted three times, and after mixing, a minute secondary is taken, sooner or later respectively take once half an hour ante cibum, and within 15 days, be a course for the treatment of.
Claims (1)
1. the psoriatic prescription for the treatment of, is characterized in that: constituent is: the Radix Rehmanniae, Radix Scrophulariae, Radix Ophiopogonis, Rhizoma Coptidis, Radix Scutellariae, Flos Lonicerae, Folium Isatidis, Hedyotidis Diffusae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, eupolyphaga, Fructus Jujubae; Constituent weight percent is: Radix Rehmanniae 11-14%, Radix Scrophulariae 5-7.5%, Radix Ophiopogonis 4-6%, Rhizoma Coptidis 3-4.6%, Radix Scutellariae 4-6%, Flos Lonicerae 11-14%, Folium Isatidis 11-14%, Hedyotidis Diffusae 11-14%, Radix Angelicae Sinensis 3.5-5%, Radix Salviae Miltiorrhizae 11-14%, eupolyphaga 5-7.5%, Fructus Jujubae 5-7.5%; Manufacture method and usage: be decocted in water for oral dose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210412884.2A CN103705722A (en) | 2012-10-09 | 2012-10-09 | Formula of drug for treating psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210412884.2A CN103705722A (en) | 2012-10-09 | 2012-10-09 | Formula of drug for treating psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103705722A true CN103705722A (en) | 2014-04-09 |
Family
ID=50399308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210412884.2A Pending CN103705722A (en) | 2012-10-09 | 2012-10-09 | Formula of drug for treating psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103705722A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169296A (en) * | 2015-11-08 | 2015-12-23 | 长沙佰顺生物科技有限公司 | Traditional Chinese medicine composition for treating psoriasis |
-
2012
- 2012-10-09 CN CN201210412884.2A patent/CN103705722A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169296A (en) * | 2015-11-08 | 2015-12-23 | 长沙佰顺生物科技有限公司 | Traditional Chinese medicine composition for treating psoriasis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102125663A (en) | Traditional Chinese medicinal preparation for treating cerebral concussion | |
| CN103272126A (en) | Traditional Chinese medicine for treating migraine | |
| CN101152372A (en) | Traditional Chinese medicine for treating children's urorrhea of liver channel damp-heat | |
| CN102652805A (en) | Medicine for treating rabies | |
| CN101721537A (en) | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis | |
| CN103845429A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN103860675A (en) | Composition for treating rheumatoid arthritis | |
| CN103301328B (en) | Trigeminal neuralgia treatment medicine | |
| CN103006997B (en) | Medicine for treating post-craniotomy headache | |
| CN105560568A (en) | Blood-activating muscle-and-tendon-relaxing traditional Chinese medicine foot bath powder | |
| CN102218132B (en) | Medicinal composition for treating nasal bleeding | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN103705722A (en) | Formula of drug for treating psoriasis | |
| CN105878454A (en) | Pharmaceutical composition for treating apoplectic hemiplegia and rheumatic arthralgia and preparation method of pharmaceutical composition | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN103285289B (en) | Traditional Chinese medicine for treating arthralgia | |
| CN103655878A (en) | Medicine for curing acute and chronic nasosinusitis through anapnotherapy | |
| CN102743661B (en) | A kind of antipsoriatics thing and preparation method thereof | |
| CN104771625A (en) | Traditional Chinese medicine for treating migraine | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| CN105343328A (en) | Health care composition | |
| CN104324208A (en) | Traditional Chinese medicine for treating neurodermatitis | |
| CN104189626A (en) | Traditional Chinese medicine used for treating eczema | |
| CN104383211A (en) | Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy | |
| CN104147263A (en) | Traditional Chinese medicine for treating neurodermatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140409 |